ZA200610232B - Fusion proteins comprising CD4 minimal modules and methods of use thereof - Google Patents

Fusion proteins comprising CD4 minimal modules and methods of use thereof

Info

Publication number
ZA200610232B
ZA200610232B ZA200610232A ZA200610232A ZA200610232B ZA 200610232 B ZA200610232 B ZA 200610232B ZA 200610232 A ZA200610232 A ZA 200610232A ZA 200610232 A ZA200610232 A ZA 200610232A ZA 200610232 B ZA200610232 B ZA 200610232B
Authority
ZA
South Africa
Prior art keywords
methods
fusion proteins
minimal modules
minimal
modules
Prior art date
Application number
ZA200610232A
Inventor
Vega Masignani
Barbara Capecchi
Susan W Barnett
Rino Rappuoli
Maria Scarselli
Victoria Sharma
Indresh K Srivastava
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Publication of ZA200610232B publication Critical patent/ZA200610232B/en

Links

ZA200610232A 2004-06-08 2006-12-06 Fusion proteins comprising CD4 minimal modules and methods of use thereof ZA200610232B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57821104P 2004-06-08 2004-06-08

Publications (1)

Publication Number Publication Date
ZA200610232B true ZA200610232B (en) 2010-05-26

Family

ID=40616710

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200610232A ZA200610232B (en) 2004-06-08 2006-12-06 Fusion proteins comprising CD4 minimal modules and methods of use thereof

Country Status (2)

Country Link
CN (1) CN101426937A (en)
ZA (1) ZA200610232B (en)

Also Published As

Publication number Publication date
CN101426937A (en) 2009-05-06

Similar Documents

Publication Publication Date Title
EP1877090A4 (en) Trimeric ox40-immunoglobulin fusion protein and methods of use
IL180554A0 (en) Rage fusion proteins and methods of use
AP2007003893A0 (en) Rage fusion proteins and methods of use
IL169638A0 (en) Soluble fcyr fusion proteins and methods of use thereof
EP1824796A4 (en) Protein scaffolds and uses thereof
EP1713440A4 (en) Engineered proteins, and methods of making and using
IL178593A0 (en) Fc??riib-specific antibodies and methods of use thereof
HK1097859A1 (en) Anti-cd38 human antibodies and uses therefor -cd38
IL206518A0 (en) HETERODIMERIC FOLLICLE STIMULATING HORMONE - Fc (FSH-Fc) FUSION PROTEINS
ZA200809394B (en) Rage fusion proteins, formulations, and methods of use thereof
GB0426397D0 (en) Fusion proteins
EP2007884A4 (en) Enzyme fusion proteins and their use
SG155260A1 (en) Antibodies against human interleukin-13 and uses therefor
HK1074052A1 (en) Anti-cd20 antibodies and fusion proteins thereof and methods of use
IL176895A0 (en) Purified interleukin-15/fc fusion protein and preparation thereof
SI2511297T1 (en) Anti-CD38 human antibodies and uses therefor
AP2007003890A0 (en) Antibodies directed against amy-loid-beta peptide and methods using same
EP1742968A4 (en) Il-13 mutein proteins, antibodies, compositions, methods and uses
EP1784513A4 (en) Fusion proteins comprising cd4 minimal modules and methods of use thereof
IL180811A0 (en) Selected fused heterocyclics and uses thereof
EP1773385A4 (en) SKIN IMMUNIZATION USING LT-STa FUSION PROTEINS
EP1813671A4 (en) Soluble protein and utilization of the same
ZA200808656B (en) Enzyme fusion proteins and their use
ZA200610232B (en) Fusion proteins comprising CD4 minimal modules and methods of use thereof
EP1735338A4 (en) Anthrax antigens and methods of use